Richard Buchholz - 09 Feb 2025 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Financial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Issuer symbol
INSP
Transactions as of
09 Feb 2025
Net transactions value
-$57,195
Form type
4
Filing time
18 Feb 2025, 18:46:47 UTC
Previous filing
18 Apr 2024
Next filing
25 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Tax liability $57,195 -314 -1.1% $182.15 27,598 09 Feb 2025 Direct F1
transaction INSP Common Stock Award $0 +5,076 +18% $0.000000 32,674 13 Feb 2025 Direct F2
holding INSP Common Stock 1,350 09 Feb 2025 Held by daughter
holding INSP Common Stock 1,350 09 Feb 2025 Held by son
holding INSP Common Stock 1,350 09 Feb 2025 Held by son
holding INSP Common Stock 1,350 09 Feb 2025 Held by son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024.
F2 Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.